ahlam1399
07-24-2015, 11:03 PM
FDA approves Sa**fi/Regeneron cholesterol drug with limits
WASHINGTON (Reuters) - The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sa**fi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a hereditary form of the condition and those with cardiovascular disease.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4869d8f3/sc/26/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=XhrfN6b7vkk:4p5lTMBciUw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=XhrfN6b7vkk:4p5lTMBciUw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=XhrfN6b7vkk:4p5lTMBciUw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=XhrfN6b7vkk:4p5lTMBciUw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=XhrfN6b7vkk:4p5lTMBciUw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/XhrfN6b7vkk
WASHINGTON (Reuters) - The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sa**fi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a hereditary form of the condition and those with cardiovascular disease.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4869d8f3/sc/26/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=XhrfN6b7vkk:4p5lTMBciUw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=XhrfN6b7vkk:4p5lTMBciUw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=XhrfN6b7vkk:4p5lTMBciUw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=XhrfN6b7vkk:4p5lTMBciUw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=XhrfN6b7vkk:4p5lTMBciUw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/XhrfN6b7vkk